Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children

Daniel J Jackson1, Ronald E Gangnon, Michael D Evans

  • 1Department of Pediatrics, University of Wisconsin-Madison, Madison, WI, USA. djj@medicine.wisc.edu

Insights

Rhinovirus (RV) infections causing wheezing in early childhood are strong predictors of developing asthma by age 6. Respiratory syncytial virus (RSV) also increases asthma risk, but RV poses a significantly higher risk.

Area of Science:

  • Pediatric Respiratory Medicine
  • Infectious Disease Epidemiology
  • Allergy and Immunology

Background:

  • Infant wheezing episodes frequently precede asthma development.
  • The specific viral causes of wheezing and their differential impact on future asthma risk are not fully understood.

Purpose of the Study:

  • To investigate the association between specific viral respiratory infections and the development of childhood asthma.
  • To identify which viral pathogens are most predictive of asthma development.

Main Methods:

  • Prospective follow-up of 259 children from birth to 6 years.
  • Nasal lavage, culture, and RT-PCR used to identify viral etiologies of wheezing illnesses.
  • Statistical analysis to assess relationships between virus-specific wheezing, risk factors, and asthma development.

Main Results:

  • Viral infections were identified in 90% of wheezing illnesses.
  • Wheezing associated with rhinovirus (RV) or respiratory syncytial virus (RSV) from birth to age 3 increased asthma risk at age 6.
  • RV wheezing by age 3 was a stronger predictor of asthma (OR, 25.6) than aeroallergen sensitization (OR, 3.4).

Conclusions:

  • Rhinovirus (RV) infections causing wheezing in early childhood are the most significant predictors of subsequent asthma development.
  • This finding is particularly relevant for high-risk birth cohorts.
Abstract

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.